InNexus Biotechnology Inc.

(IXS:CA)

By |

Profile

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

Contact Information

Website: www.ixsbio.com
Main Phone: +1 480 862-7500
Address: 1500 Royal Centre
Address 2: 1055 West Georgia Street
State: BC
City / Town: Vancouver
Country: CAN
Postal Code: V6E 4N7

Issuer Information

Exchange: CDX
NAICS: Pharmaceutical P
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 126,270,651.00 EPS (TTM) N/A PE Ratio N/A Exchange TSXV